Featured Products
more+
-
Dicobalt octacarbonylCAS:10210-68-1Molecular Formula:Co2(CO)8 -
4,4'-(1,2-Ethanediyl)bis[alpha-methylbenzenemethanol]CAS:38147-31-8Molecular Formula:C18H22O2 -
7-(4-Ethyl-1-methyloctyl)-8-hydroxyquinolineCAS:73545-11-6Molecular Formula:C20H29NO -
5-Chloro-2-cyclopropyl-6-hydroxypyrimidine-4-carboxylic acidCAS:858956-26-0Molecular Formula:C8H7ClN2O3 -
4-Chloro-2-nitrobenzoic acidCAS:6280-88-2Molecular Formula:C7H4ClNO4 -
(3-Aminopropyl)bis[3-(dimethylamino)propyl]amineCAS:65604-92-4Molecular Formula:C13H32N4 -
3-Cyano-4-fluorophenylboronic acidCAS:214210-21-6Molecular Formula:C7H5BFNO2 -
tert-Butyl 3-fluoro-4-oxopiperidine-1-carboxylateCAS:211108-50-8Molecular Formula:C10H16FNO3
New Arrivals
more+
-
OxytocinCAS:50-56-6Molecular Formula:C43H66N12O12S2 -
N-Acetyl-D-alanineCAS:19436-52-3Molecular Formula:C5H9NO3 -
5-bromo-3,3-dimethyl-2,3-dihydro-1H-isoindol-1-oneCAS:959756-18-4Molecular Formula:C10H10BrNO -
2,2-Dimethylpropylamine hydrochlorideCAS:15925-18-5Molecular Formula:C5H13N.HCl -
(1R,3S,5R)-2-(tert-butoxycarbonyl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxylic acidCAS:1306734-44-0Molecular Formula:C12H19NO4 -
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acidCAS:641569-94-0Molecular Formula:C17H14N4O2 -
(3,3-Difluoro-1-Methyl-cyclobutyl)MethanolCAS:1408076-35-6Molecular Formula:C6H10F2O -
2-hydroxy-4-tetradecyl-1,3,2-dioxaborolaneCAS:84819-41-0Molecular Formula:C16H33BO3
Contact us
Email::[email protected]
News
more+
-
11-26Allegro Ophthalmics Announces Positive Results of Vehicle-controlled Ex-U.S. Phase 2 Trial of ALG-1007 for the Treatment of Dry Eye DiseaseAllegro Ophthalmics, LLC, a privately held biopharmaceutical company focused on the development of novel oxidative stress stabilizers for the treatment of ocular diseases, today announced that all primary and secondary endpoints of an ex-U.S. vehicle-cont
-
11-15Janssen Licenses "Flexible Antibody" Technology from F-star in New CollabClinical-stage biopharma company F-star Therapeutics announced a new partnership with Janssen Biotech on Wednesday, only one month after presenting an optimistic trial-in-progress update to the public on its tetravalent dual T-cell agonist FS120 at the Eu
-
11-09Palleon to Present Preclinical Data on Lead Immuno-Oncology Program, E-602, at SITC Annual MeetingWALTHAM, Mass.--(BUSINESS WIRE)--Palleon Pharmaceuticals, a company pioneering the field of glyco-immunology to treat cancer and inflammatory diseases, today announced it will present new preclinical data on the company’s lead immuno-oncology program, E
Technical FAQ
more+
Services
Notice